Sufentanil citrate is a new synthetic opiate analgesic ~ which is about 4500 times as potent as morphine and five to ten times as potent as fentanyl. 2 Sufentanil has a much higher therapeutic ratio, faster onset of action and shorter terminal elimination half-life than fentanyl. 3 These characteristics have led to the use of sufentanil as the principal anaesthetic agent in aorto-coronary bypass operations. 4 Sufentanil has been thought to provide similar haemodynamic stability in equipotent doses to that of fentanyl. Current anaesthetic techniques for coronary artery bypass surgery strive for amelioration or elimination of significant stress responses as reflected by fluctuations in plasma catecholamines, plasma vasopressin and haemodynamic stability. Attenuation of such stress responses is felt to lessen the adverse effects of vascular smooth muscle constriction and minimize changes in myocardial oxygen demands. Previous work from this centre has shown fentanyl has little effect on plasma vasopressin levels during bypass. Haemodynamic stability during tracheal intubation was maintained. Sternotomy resulted in significant haemodynamic instability. 3~ Haemodynamic variability was a characteristic of the high-dose fentanyl used (50-100 I~g-kg -t) in that study. The present study was done to evaluate the use of larger doses of fentanyl (in the range of 125txg'kg -l) and to compare this approach with the use of sufentanil (in the range of 25 Ixg.kg -l) in a further effort to obtain haemodynamic stability. Vasopressin responses were assessed as a reflection of the physiological milieu of the patients.
Methods
Fourteen patients (age 44 to 68) scheduled for elective coronary artery bypass surgery were studied, after obtaining informed consent at a preoperative visit. The protocol was approved by both the University and the Hospital Human Research Committees. All the patients were ASA physical status Class III or IV scheduled to have first-time coronary artery bypass grafts. Patients were selected with normal preoperative cardiovascular dynamics. All patients were normotensive and had adequate left ventricular function with left ventricular end diastolic pressures of <20 mmHg and ejection fractions >0.5. Patients were randomly assigned to the fentanyl and sufentail groups. Demographic and concurrent medication data are shown in Tables I and II. Patients were premedicated with oral lorazepam 2rag and intramuscular morphine 0.15mg.kg -I one hour preoperatively. Beta-adrenergic blocking agents, calcium channel blocking agents and nitrates were continued up to one to two hours prior to the time of surgery. Electrocardiograph monitoring leads (Vs) were connected after the patients arrived in the operating room. Peripheral venous, central venous, radial artery and pulmonary artery catheters were inserted under local anaesthesia. The Oximetric | flow directed balloon-tipped thermodilution pulmonary artery catheter was inserted via the right intemal or external jugular vein. Haemodynamic measurements and blood samples were then taken for control values.
An oesophageal temperature probe and urinary catheter were inserted after induction. Pancuronium 0.02mg.kg -1 was given intravenously and followed by three minutes of 100 per cent oxygen by face mask. This was followed by either sufentanil 7.5 ixg.kg -t or fentanyl 37.5 v,g.kg -~ by intravenous infusion over three minutes. Ventilation was assisted manually, as necessary, with 100 per cent oxygen, lntubation was facilitated by the administration of succinylcholine 1.5 mg.kg-~ intravenously. All patients were then mechanically ventilated with 100 per cent oxygen to maintain normocapnia (PaCO2 35-40 mmHg). Pancuronium 0.08mg.kg -t was given within 13 minutes of the start of the narcotic infusion. Muscle relaxation was maintained using 0.04 mg.kg-1 increments of pancuronium every 45 to 60 minutes. Pancuronium 0.04mg.kg -t was administered to all patients just prior to cardiopulmonary bypass. Sufentanil 3.75 v,g'kg -t or fentany118.75 v,g.kg -l were given intravenously three minutes prior to skin incision and three minutes prior to sternotomy resulting in total pre-stemotomy doses of 15 i~g-kg -~ or 75 v,g'kg-t for sufentanil and fentanyl respectively.
The criteria for hypertension were a rise in systolic blood pressure of at least 15 per cent above the control level or a mean blood pressure on cardiopulmonary bypass of more than 100 mmHg. Either of these events was treated with additional doses of 2.5 Ixg.kg -~ of sufentanil or 12.5 ~g.kg -t of fentanyl administered by bolus injection. Failure of two successive doses of narcotics to return the blood pressure to below these levels within five minutes resulted in the institution of vasodilator therapy using sodium nitroprusside or nitroglycerine infusions. An Optiflo | II bubble oxygenator was primed with two litres of Plasmalyte | and patients were heparinized with 300 units'kg -l sodium heparin. Blood products were administered as necessary to maintain adequate filling pressures. Patients were cooled to 30 ~ C during cardiopulmonary bypass and re-warmed to at least 37~ at its conclusion. All patients were electively ventilated overnight.
Heart rate, systolic, diastolic and mean blood pressures, right atrial pressure, pulmonary diastolic and capillary wedge pressures were recorded before induction (TO, at the end of induction prior to intubation (T2), post-intubation (T3), pre-skin incision (T4), post-skin incision (Ts), post-sternotomy (Tt), pre-bypass (T7) , end of bypass (Ts), postprotamine (T13), post-sternal closure (T~4), and thirty minutes after arrival in the intensive care unit (Tl~). Cardiac output measurements were performed in triplicate at the same interval. Mean blood pressures were recorded on bypass at three (Ts), 15 (T9), 30 (TIo), 60 minutes (Tl0 and just prior to coming off bypass (T12). Blood and urine samples were collected at all the above times. Plasma arginine vasopressin (AVP), serum electrolytes, serum osmolality, plasma proteins, urine electolytes, urine osmolality and haematocrit were also measured at these times. Blood samples for AVP were also collected on the day prior to surgery (To). Cardiac index, systemic vascular resistance, pulmonary vascular resistance and left ventricular stroke work index were calculated for all nonbypass sampling times.
The blood samples for AVP assay were collected in EDTA tubes, placed on ice and the plasma separated by centrifuge within one hour. The plasma was stored at -20 ~ C until radioimmunoassay. The AVP was measured following extraction of plasma with organic solvents using a previously described ILIA system: The AVP values were corrected for extraction losses.
All patients in this study were interviewed by one of the authors (A.B.) three days postoperatively for evaluation of intraoperative awareness, and adequacy of the anaesthetic technique. The patients were asked what the first thing was which they remembered after the start of their anaesthetic and how they rated their anaesthetic subjectively given the choice of good, satisfactory or bad. Descriptive statistics and independent "t-tests" between the sufentanil group (N = 7) and the fentanyl group (N = 7) were performed by the Statistical Package for the Social Services (SPSS). Repeated measures analysis for comparisons with each group were performed using analysis of variance. Bonferoni multiple contrasts guaranteeing overall p < 0.05 were considered significant. Results are expressed as mean • standard error of the mean.
Results
The doses were 128 ---8.7 I~g'kg-t (mean ---SE) of fentanyl and 23 • 1.41~g-kg -t (mean ---SE) of sufentanil. The mean age, weight and height in the two groups were similar (Table I ). Concurrent medication use was similar (Table II) . There was no statistically significant difference between the fentanyl and sufentanil groups with respect to any of the measured or derived haemodynamic data, neither were there significant changes within the groups (Table III , IV, V, VI). Mean duration of bypass was 117 • 14 minutes for the fentanyl groups and 118 --+ 12 minutes for the sufentanil groups (M --. SE).
Haemodyamic data -fentanyl group
All patients became hypertensive following intubation, post-skin incision and/or post-sternotomy. Five of these patients required vasodilator therapy for control of blood pressure. Two of these patients exhibited S-T depression (> 1 mm) associated with hypertension, both of which responded to intravenous nitroglycerine infusion (1 ixg.kg-l.min-t). Both of these patients subsequently moved, despite receiving 125 p.g.kg -~ of fentanyl. Isoflurane (0.5 per cent) was added to their anaesthetic regime. Five patients became hypertensive during bypass and all required vasodilator therapy. One patient be- Haemodyamic data -sufentanil group 
Other results
Plasma arginine vasopressin (AVP) remained at basal levels until the start of bypass. AVP levels then increased in both groups with that of the fentanyl group being significantly increased ( Figure   1 - Table VI ). All patients in the sufentanil groups had increased AVP levels post-bypass, and one patient had very high AVP levels post-bypass. This coincided with hypertension requiring vasodilators.
The AVP values for this patient increased by 15 times on bypass and by 30 times in the PAR. Three sufentanil patients and four fentanyl patients developed mild chest rigidity which did not compromise the anaesthetic. No patient remembered any aspect of the laryngoscopy, intubation or operation. The first event recalled by patients was awakening in the intensive care unit. All patients rated the anaesthetic as good.
Plasma protein levels on the day prior to surgery were 8.49 -0.30g.dl -t (M • SE) in the fentanyl and 8.05 • 0.11 g'dl-l in the sufentanil patients. Plasma proteins decreased in all patients during bypass, reaching 3.85 • 0.19 g.dl-t (fentanyl) and 3.99 ---0.17g.dl -I (sufentanil) at mid-bypass. (Table VI) in either patient group. Osmolar clearance increased during bypass in the fentanyl patients and after bypass in the sufentanil patients (Table VI) . Osmolar clearance changes were paralleled by changes in sodium clearance. Increases in plasma AVP in both groups of patients do not correspond to the times of increased osmolar clearance.
Discussion
The use of large doses of opiate analgesics as the "complete anaesthetic" was stimulated by the observation of Lowenstein et al. 6 in 1969 that I mgkg-i of morphine in a dose of 1.0 mg'kg-i produced minimal alterations in cardiovascular haemodynamics in patients with aortic valve disease. Morphine in 1-3 mg-kg -I doses is associated with problems including hypotension, 7"s hypertension, 9 cardiovascular depression when nitrous oxide is added,I~ increased blood and fluid requirements I i and awareness, i2 Anaesthesia with fentanyl 50-100 p,g.kg -1 was proposed by Stanley et al. as an improvement over morphine, providing gi'eater cardiovascular stability. I2'13 Fentanyl also suppresses the hormonal response to induction and surgery, although not to cardiopulmonary bypass. 14-16 Not everyone has been able to reproduce these results while the most common cardiovascular disturbance with high dose fentanyl anaesthesia is hypertension after stemotomy with a reported incidence of 0 to 100 per cent. 12.17,1s Several cases of intraoperative awareness have also been reported. These problems have led to the use of higher doses of fentany132 (up to 150 I~g'kg-i) with the possible attendant increase in postoperative respiratory depression.
It has been suggested that the more potent an opiate analgesic is, the less will be the incidence of side-effects and the greater the cardiovascular stability. 2~ If this is so, then sufentanil should represent an improvement over fentanyl. Initial studies comparing sufentanil and fentanyl for coronary artery bypass surgery tended to support this, with sufentanil giving a reduced incidence of hypertension and tachycardia and being more effective in controlling it when it did occur. 22'24 However, three recent reports found no difference in the incidence of hypertension between fentanyl and sufentanil even with sufentanil dosages up to 30 ~g-kg -t. [24] [25] [26] In our study, the incidence of "breakthrough hypertension" following intubation, post-skin incision and/or post-sternotomy was high in both patient groups.
While there was no difference between the fentanyl and sufentanil groups, in the sufentanil group the hypertension responded well to treatment with additional sufentanil. In contrast patients in the fentanyl group required vasodilator therapy in most (five of seven) cases. A recent report claims success in avoiding hypertension by using a rapid sequence induction technique (fentanyl 50 Ixg.kg -1 over 20 seconds); however, no data on haemodynamic responses to sternotomy or cardiopulmonary bypass are given.3 t Arginine vasopression (AVP) is considered one of the body's stress-responding hormones.~4 '29 Concentrations of AVP in plasma have been reported to increase during anaesthesia and surgery. 27 Fentanyl has been shown to block the AVP elevation prior to, but not during, cardiopulmonary bypass. 14'3~ Increases in AVP were also seen in patients anaesthetized with halothane and morphine. 28 The increase in plasma AVP during cardiopulmonary bypass was reported by deLange etal. to be abolished with alfentanil and with sufentanil. 29 This study shows that cessation of bypass is associated with AVP levels which increase transiently with sufentanil and decrease with fentanyl. These findings could be ascribed to the shorter duration of sufentanil and the ability of fentanyl to redistribute in body compartments. observation of an increase in AVP prior to the end of surgery. DeLange has further data, as yet unpublished, suggesting the stress response as reflected by plasma levels of catecholamines, may not be suppressed by sufentanil. Such data would support an increased level of AVP as a trend indicator of the stress response but not a transient increase. More importantly, the more frequent sampling intervals used in our study may have revealed a previously unsuspected transient increase in AVP levels.
Plasma concentrations of AVP in patients treated with fentanyl in our study were within the normal range following induction, skin incision and sternotomy, but were found to be elevated during the bypass period (Figure) . AVP concentrations returned to basal levels in the post-bypass period. These data are in agreement with those of our previous study 3~ in which plasma AVP concentrations were compared during high-dose fentanyl and halothane anaesthesia 9 The elevations of AVP during bypass seen in both of our studies were modest (to 7-18 pg-ml -l) and were thus not likely to adversely affect peripheral vascular resistance in those patients. The high AVP levels observed by Stanley et al. , 4 have not been recorded in either of our patient series.
In summary, no differences were detected between the two anaesthetic regimens with respect to cardiovasuclar variables, serum osmolality, electrolyte concentrations, haematocrit, plasma protein concentrations, and free water clearance. Modest transient increases in plasma AVP seen during the bypass period in the fentanyl patients were attenu-ated in the sufentanil group. However, in the post-bypass period the sufentanil patients exhibited an "escape" from this attenuation, and AVP concentrations in plasma increased. A similar incidence of hypertensive episodes was observed in both groups of patients, but the sufentanil group required less frequent use of vasodilators. However, on the basis of our experience, neither fentanyl in doses of 128 -+ 8.7 ttg.kg -I nor sufentanil in doses of 23 ---1.4 tzg.kg -1 can be used as sole agents for anaesthesia in coronary artery bypass patients.
